# Achieve Life Sciences, Inc.: Form 8-K, filed May 12, 2026

- Company: [Achieve Life Sciences, Inc.](/companies/achv.md) (CIK 949858)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 07:20 ET
- Period: 2026-05-07
- Accession: 0001193125-26-218175
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/949858/000119312526218175/d854692d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/949858/000119312526218175/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/949858/000119312526218175/d854692d8k.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-218175. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
